Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
Naronapride by Renexxion for Corrosive Esophagitis (Erosive Esophagitis): Likelihood of Approval
Naronapride is under clinical development by Renexxion and currently in Phase II for Corrosive Esophagitis (Erosive Esophagitis). According to GlobalData,...